Ivor S Douglas Selected Research

Cadherins (E-Cadherin)

11/2016	Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury.
3/2006	Beta-catenin in the fibroproliferative response to acute lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ivor S Douglas Research Topics

Disease

15	Sepsis (Septicemia) 05/2024 - 11/2008
12	Critical Illness (Critically Ill) 05/2024 - 03/2014
11	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 10/2009
8	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2024 - 01/2011
8	Inflammation (Inflammations) 11/2023 - 05/2005
8	Infections 01/2023 - 02/2013
7	COVID-19 11/2023 - 01/2021
7	Septic Shock (Toxic Shock Syndrome) 10/2020 - 11/2008
7	Lung Injury 11/2016 - 03/2006
6	Acute Kidney Injury (Acute Renal Failure) 06/2024 - 01/2007
5	Shock 01/2020 - 09/2011
4	Pneumonia (Pneumonitis) 05/2022 - 04/2016
4	Chronic Obstructive Pulmonary Disease (COPD) 11/2017 - 11/2006
3	Heart Failure 10/2023 - 11/2017
3	Acute Lung Injury 09/2011 - 03/2006
2	Hypotension (Low Blood Pressure) 05/2024 - 11/2023
2	Delirium 04/2024 - 12/2018
2	Neoplasms (Cancer) 12/2023 - 06/2015
2	Edema (Dropsy) 01/2021 - 10/2018
2	Necrosis 06/2014 - 03/2006
2	Hypovolemia 02/2013 - 02/2013
2	Hemorrhage 02/2013 - 02/2013
2	Low Cardiac Output 02/2013 - 02/2013
2	Hypoxia (Hypoxemia) 02/2013 - 02/2013
2	Ulcer 02/2013 - 02/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2013 - 02/2013
2	Death (Near-Death Experience) 02/2013 - 02/2013
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 02/2013 - 02/2013
2	Venous Thrombosis (Deep-Vein Thrombosis) 02/2013 - 02/2013
2	Pulmonary Edema 09/2011 - 10/2008
1	Frailty 12/2023
1	Hypersensitivity (Allergy) 11/2023

Drug/Important Bio-Agent (IBA)

5	Oxygen (Dioxygen)IBA 11/2023 - 02/2013
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 06/2006
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 02/2013
5	Proteins (Proteins, Gene)FDA Link 11/2016 - 03/2006
4	Vasopressins (Vasopressin)IBA 10/2021 - 02/2013
3	Hemoglobins (Hemoglobin)IBA 05/2024 - 02/2013
3	CytokinesIBA 01/2017 - 01/2007
3	GlycosaminoglycansIBA 01/2016 - 03/2014
3	AlbuminsIBA 10/2015 - 02/2013
3	Crystalloid SolutionsIBA 10/2015 - 02/2013
3	ChemokinesIBA 10/2008 - 05/2005
2	DiureticsIBA 06/2024 - 10/2023
2	Haloperidol (Haldol)FDA LinkGeneric 04/2024 - 12/2018
2	ziprasidone (Geodon)FDA Link 04/2024 - 12/2018
2	Antipsychotic Agents (Antipsychotics)IBA 04/2024 - 12/2018
2	LigandsIBA 11/2023 - 01/2018
2	tocilizumab (atlizumab)FDA Link 05/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2021 - 11/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2008
2	EphA2 ReceptorIBA 01/2018 - 11/2016
2	LipopolysaccharidesIBA 11/2016 - 08/2007
2	Cadherins (E-Cadherin)IBA 11/2016 - 03/2006
2	DisaccharidesIBA 06/2015 - 03/2014
2	Cisplatin (Platino)FDA LinkGeneric 06/2014 - 01/2007
2	CreatinineIBA 06/2014 - 12/2011
2	Heparitin Sulfate (Heparan Sulfate)IBA 03/2014 - 08/2012
2	Lipid AIBA 01/2014 - 08/2007
2	Glucose (Dextrose)FDA LinkGeneric 02/2013 - 02/2013
2	Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link 02/2013 - 02/2013
2	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2013 - 02/2013
2	Dopamine (Intropin)FDA LinkGeneric 02/2013 - 02/2013
2	Vasodilator Agents (Vasodilators)IBA 02/2013 - 02/2013
2	Neuromuscular Blocking AgentsIBA 02/2013 - 02/2013
2	Insulin (Novolin)FDA Link 02/2013 - 02/2013
2	Dobutamine FDA LinkGeneric 02/2013 - 02/2013
2	Blood Glucose (Blood Sugar)IBA 02/2013 - 02/2013
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2013 - 02/2013
2	Epinephrine (Adrenaline)FDA LinkGeneric 02/2013 - 02/2013
2	drotrecogin alfa activated (Xigris)FDA Link 05/2012 - 11/2008
2	Protein CIBA 05/2012 - 11/2008
2	Peroxidase (Myeloperoxidase)IBA 10/2008 - 01/2007
2	IntegrinsIBA 09/2007 - 03/2006
1	EnzymesIBA 05/2024
1	LipidsIBA 05/2024
1	Acetaminophen (Paracetamol)FDA LinkGeneric 05/2024
1	angiotensin I (1-7)IBA 11/2023
1	Type 1 Angiotensin ReceptorIBA 11/2023
1	Angiotensin IIIBA 11/2023
1	dimemorfan (AT 17)IBA 08/2023

Therapy/Procedure

9	Therapeutics 01/2023 - 05/2005
8	Resuscitation 10/2023 - 02/2013
7	Artificial Respiration (Mechanical Ventilation) 01/2022 - 10/2009
5	Critical Care (Surgical Intensive Care) 01/2020 - 01/2007
3	Resuscitation Orders (Do Not Resuscitate Orders) 08/2023 - 01/2017
3	Noninvasive Ventilation 11/2017 - 10/2016
2	Tracheostomy 12/2023 - 11/2019
2	Laryngoscopes 08/2023 - 01/2023
2	Length of Stay 01/2021 - 12/2020
2	Patient Readmission 01/2017 - 09/2013
2	Cannula 02/2013 - 02/2013
2	Renal Dialysis (Hemodialysis) 02/2013 - 02/2013
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 02/2013 - 02/2013
2	Continuous Renal Replacement Therapy 02/2013 - 02/2013
2	Mechanical Ventilators (Ventilator) 09/2011 - 10/2009
2	Nephrectomy 10/2008 - 01/2007
1	Aftercare (After-Treatment) 04/2024
1	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2023
1	Precision Medicine 11/2023